Bloomage Biotechnology Corp Stock Beta
| 688363 Stock | 59.16 1.32 2.28% |
Bloomage Biotechnology Corp fundamentals help investors to digest information that contributes to Bloomage Biotechnology's financial success or failures. It also enables traders to predict the movement of Bloomage Stock. The fundamental analysis module provides a way to measure Bloomage Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bloomage Biotechnology stock.
Bloomage | Beta |
Bloomage Biotechnology Corp Company Beta Analysis
Bloomage Biotechnology's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Bloomage Biotechnology Beta | 0.87 |
Most of Bloomage Biotechnology's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bloomage Biotechnology Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Bloomage Biotechnology Corp has a Beta of 0.868. This indicator is about the same for the Chemicals average (which is currently at 0.87) sector and 21.09% lower than that of the Materials industry. The beta for all China stocks is notably lower than that of the firm.
Bloomage Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bloomage Biotechnology's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bloomage Biotechnology could also be used in its relative valuation, which is a method of valuing Bloomage Biotechnology by comparing valuation metrics of similar companies.Bloomage Biotechnology is currently under evaluation in beta category among its peers.
Bloomage Biotechnology returns are very sensitive to returns on the market. As the market goes up or down, Bloomage Biotechnology is expected to follow.
Bloomage Fundamentals
| Return On Equity | 0.062 | ||||
| Return On Asset | 0.0319 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 28.26 B | ||||
| Shares Outstanding | 481.68 M | ||||
| Shares Owned By Insiders | 61.00 % | ||||
| Shares Owned By Institutions | 16.57 % | ||||
| Price To Book | 4.06 X | ||||
| Price To Sales | 4.97 X | ||||
| Revenue | 6.08 B | ||||
| Gross Profit | 6.36 B | ||||
| EBITDA | 664.83 M | ||||
| Net Income | 592.56 M | ||||
| Total Debt | 153.13 M | ||||
| Book Value Per Share | 14.67 X | ||||
| Cash Flow From Operations | 699.65 M | ||||
| Earnings Per Share | 0.91 X | ||||
| Target Price | 56.46 | ||||
| Number Of Employees | 4.66 K | ||||
| Beta | 0.87 | ||||
| Market Capitalization | 28.5 B | ||||
| Total Asset | 8.47 B | ||||
| Retained Earnings | 2.45 B | ||||
| Working Capital | 1.9 B | ||||
| Net Asset | 8.47 B | ||||
| Last Dividend Paid | 0.38 |
About Bloomage Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bloomage Biotechnology Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bloomage Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bloomage Biotechnology Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Bloomage Stock
Bloomage Biotechnology financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology security.